
CAS 162515-69-7
:Montelukast Sodium
Description:
Montelukast sodium is a leukotriene receptor antagonist primarily used in the management of asthma and allergic rhinitis. It functions by inhibiting the action of leukotrienes, which are inflammatory mediators that contribute to bronchoconstriction and mucus production. This compound is typically administered orally and is available in various formulations, including tablets and chewable forms. Montelukast sodium is characterized by its high solubility in water and its ability to cross biological membranes, allowing it to exert its therapeutic effects effectively. The substance is generally well-tolerated, with common side effects including headache, gastrointestinal disturbances, and, in rare cases, mood changes. Its pharmacokinetics indicate that it has a relatively long half-life, permitting once-daily dosing. Montelukast sodium is often prescribed as a preventive treatment rather than a rescue medication, making it an essential component in the long-term management of asthma and allergic conditions.
Formula:C6H11NOS
Synonyms:- Cyclopropaneacetamide, 1-(mercaptomethyl)-
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
